-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Caris Life Sciences, Maintains $32 Price Target

Benzinga·07/02/2026 10:23:33
Listen to the news
BTIG analyst Mark Massaro reiterates Caris Life Sciences (NASDAQ:CAI) with a Buy and maintains $32 price target.